Bruce Hiscock Acquires 24 Shares of Bioventix PLC (LON:BVXP) Stock

Bioventix PLC (LON:BVXP) insider Bruce Hiscock purchased 24 shares of the stock in a transaction on Friday, November 22nd. The stock was acquired at an average price of GBX 3,822 ($47.91) per share, for a total transaction of £917.28 ($1,149.91).

Bruce Hiscock also recently made the following trade(s):

• On Wednesday, October 30th, Bruce Hiscock acquired 300 shares of Bioventix stock. The shares were acquired at an average price of GBX 3,330 ($41.75) per share, with a total value of £9,990 ($12,523.51).

Bioventix Stock Performance

LON:BVXP opened at GBX 3,750 ($47.01) on Friday. Bioventix PLC has a 52-week low of GBX 2,977 ($37.32) and a 52-week high of GBX 5,100 ($63.93). The company has a market cap of £195.75 million, a P/E ratio of 2,300.61 and a beta of 0.35. The stock’s 50-day simple moving average is GBX 3,771.85 and its 200 day simple moving average is GBX 4,103.89.

Bioventix Increases Dividend

The business also recently declared a dividend, which was paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th were given a dividend of GBX 87 ($1.09) per share. This is a positive change from Bioventix’s previous dividend of $68.00. The ex-dividend date was Thursday, November 7th. This represents a dividend yield of 2.4%. Bioventix’s payout ratio is 9,693.25%.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.